« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 16, Issue 1,
Supplement
, Pages S64-S67
, January 2010
Severe Sickle Cell Disease—Pathophysiology and Therapy
References
- Prediction of adverse outcomes in children with sickle cell disease. N Eng J Med. 2000;342:83–89
- Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newbron Cohort. Blood. 2008;111:544–548
- Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood. 2006;108:2923–2927
- . Pulmonary complications of sickle cell disease. N Engl J Med. 2008;359:2254–2265
- Matched-related transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol. 2007;137:479–485
- Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 2001;7:665–673
- Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003;101:2137–2143
- . Cerebrovascular accidents in sickle cell disease rates and risk factors. Blood. 1998;91:288–294
- . Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Peds. 2002;140:348–354
- Availability of related donors for bone marrow transplantation in sickle cell anemia. Am J Pediatr Hematol Oncol. 1994;16:27–29
- Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies. Bone Marrow Transplant. 2003;31:547–550
- Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood. 1995;85:879–884
- Sibling donor cord blood transplantation for thalassemia major: experience of the sibling donor cord blood program. Ann N Y Acad Sci. 2005;1054:206–213
- . A novel reduced-intensity stem cell transplant regimen for non-malignant disorders. Bone Marrow Transplant. 2005;35:345–352
- Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant. 2008;14:1270–1278
- . Analysis of 608 umbilical cord blood (UCB) transplants: HLA-Match is a critical determinant of transplant related mortality (TRM) in the post-engraftment period even in the absence of acute graft versus host disease (aGVHD). Blood. 2005;106:Abstract #303
- Higher mortality after allogeneic peripheral blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source working Committee of the International Bone Marrow transplant Registry. J Clin Oncol. 2004;22:4872–4880
- Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 1996;2:100–104
- Bone marrow transplantation for sickle cell disease. A study of parents' decisions. N Eng J Med. 1991;325:1349–1353
- Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore). 2005;84:363–376
- . Mortality in sickle cell patient transitioning from pediatric to adult program: 10 years grady comprehensive sickle cell center experience. Blood. 2008;112:Abstract #1426
- . Outcome of transitioning pediatric patients with sickle cell disease to adult programs. Blood. 2004;104:Abstract 3743
- . Pulmonary complications of sickle cell disease. N Engl J Med. 2008;359:2254–2265
- Abnormal pulmonary function in adults with sickle cell anemia. Am J Respir Crit Care Med. 2006;173:1264–1269
- Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol. 2006;17:2228–2235
- High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol. 2006;81:236–241
- . Predictors of in-hospital mortality and charges in sickle cell disease: results from the California Discharge Databases 1998-2005. Blood. 2007;110:Abstract #432
- Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes. 2005;3:50
Financial disclosure: See Acknowledgments on page S66.
PII: S1083-8791(09)00457-1
doi: 10.1016/j.bbmt.2009.10.001
© 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 16, Issue 1,
Supplement
, Pages S64-S67
, January 2010
